Home Watchlists Portfolios Indices Forex Futures Market Scan Chart Settings

Reviewing Miragen Therapeutics Inc. (MGEN)'s and Exact Sciences Corporation (NASDAQ:EXAS)'s results



  • Source: Stocks Beat - - Read: 0

    Summary:

     

    This is therefore a comparing of the profitability, analyst recommendations, institutional ownership, risk, dividends, earnings and valuation in Miragen Therapeutics Inc. (NASDAQ:MGEN) and Exact Sciences Corporation (NASDAQ:EXAS). The two are both Medical Laboratories & Research companies that compete with one another.

    Earnings and Valuation

    Gross Revenue

    Price/Sales Ratio

    Net Income

    Earnings Per Share

    Price/Earnings Ratio

    Miragen Therapeutics Inc.

    3

    5.99

    N/A

    -1.29

    0.00

    Exact Sciences Corporation

    101

    24.56

    N/A

    -1.76

    0.00

    Table 1 highlights Miragen Therapeutics Inc. and Exact Sciences Corporation’s top-line revenue, earnings per share and valuation.

    Profitability

    Table 2 hightlights the return on equity, net margins and return on assets of the two companies.

    Net ...

     

     

    Read Full News: https://stocksbeat.com/2019/08/15/trending-stock-news/reviewing-miragen-therapeutics-inc-mgens-and-exact-sciences-corporation-nasdaqexass-results/


Log in to reply